Kazia Therapeutics Limited - ADR

Kazia Therapeutics Limited - ADR

KZIA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$20.66M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kazia Therapeutics Limited - ADRKazia Therapeutics Limited - ADR-0.9--98%--
$34.50

Target Price by Analysts

421.1% upsideKazia Therapeutics Limited Target Price DetailsTarget Price
$2.43

Current Fair Value

63.3% downside

Overvalued by 63.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$20.66 Million
Enterprise Value$-48,635,144.00
Earnings per Share$-18.9
Beta2.36
Outstanding Shares3,120,426

Return

Return on Equity-97.92%ROE
Return on Assets-63.98%
Return on Invested Capital-90.83%

Valuation & Multiples

P/E Ratio-0.94P/E Ratio
PEG-0.7PEG
Price to Sales-Price to Sales
Price to Book Ratio0.47Price to Book Ratio
Enterprise Value to Revenue-23.32
Enterprise Value to EBIT1.38
Enterprise Value to Net Income1
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 4, 2026
EPS
-$0.33
Est. -$0.61
Revenue
$150,394
Est. $488,858

Next Earnings Call

Expected Date
March 2, 2027
EPS Estimate
-$0.07
Consensus analyst estimate
Revenue Estimate
$1.99 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.85, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.8506▲ 76.70%
Total Calls15,400▼ 95.79%
Total Puts13,100▼ 57.19%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %78.86%▼ 37.77%
Total Invested$23.61M▼ 53.45%
Investors Holding32▼ 9.00%

About Kazia Therapeutics Limited

Kazia Therapeutics Limited Insider Information FAQ

Stockcircle tracks 2 top investors with a current 13F position in Kazia Therapeutics Limited. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.